These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27488429)

  • 21. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment.
    Zhang X; Liu XJ; Hu S; Schindler TH; Tian Y; He ZX; Gao R; Wu Q; Wei H; Sayre JW; Schelbert HR
    J Nucl Med; 2008 Aug; 49(8):1288-98. PubMed ID: 18632821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization.
    Knuesel PR; Nanz D; Wyss C; Buechi M; Kaufmann PA; von Schulthess GK; Lüscher TF; Schwitter J
    Circulation; 2003 Sep; 108(9):1095-100. PubMed ID: 12939229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
    Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
    Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
    J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of myocardial viability by FDG-PET].
    Momose M; Kondo C
    Rinsho Byori; 2007 Jul; 55(7):639-47. PubMed ID: 17718060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.
    Beanlands RS; Hendry PJ; Masters RG; deKemp RA; Woodend K; Ruddy TD
    Circulation; 1998 Nov; 98(19 Suppl):II51-6. PubMed ID: 9852880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Washout of ⁸²Rb as a marker of impaired tissue integrity, obtained by list-mode cardiac PET/CT: relationship with perfusion/metabolism patterns of myocardial viability.
    Chien DT; Bravo P; Higuchi T; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1507-15. PubMed ID: 21528386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
    Ghesani M; Depuey EG; Rozanski A
    Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography for assessment of viability.
    Sawada SG
    Curr Opin Cardiol; 2006 Sep; 21(5):464-8. PubMed ID: 16900009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms.
    Bax JJ; Visser FC; Poldermans D; Elhendy A; Cornel JH; Boersma E; Valkema R; Van Lingen A; Fioretti PM; Visser CA
    J Nucl Med; 2001 Jan; 42(1):79-86. PubMed ID: 11197985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
    Slart RH; Zeebregts CJ; Hillege HL; de Sutter J; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Tio RA
    J Nucl Med; 2011 Jun; 52(6):873-9. PubMed ID: 21571798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
    Lund GK; Freyhoff J; Schwaiger M; Lübeck M; Lund CH; Buchert R; Sheehan FH; Meinertz T; Nienaber CA
    Cardiology; 2002; 98(4):202-9. PubMed ID: 12566650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of viable myocardium assessed by 99Tcm-MIBI SPECT and 18F-FDG PET imaging on clinical outcome of patients with left ventricular aneurysm underwent revascularization].
    Zhang XL; Liu XJ; Hu SS; Thomas S; Tian YQ; Gao RL; Wu QY; Wei HX; Yang XB; Wang H; He ZX; Schelbert HR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):999-1003. PubMed ID: 19102913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction.
    Maddahi J; Schelbert H; Brunken R; Di Carli M
    J Nucl Med; 1994 Apr; 35(4):707-15. PubMed ID: 8151399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.